XML 25 R61.htm IDEA: XBRL DOCUMENT v3.2.0.727
Financial Information for the Company and Its Subsidiaries (Income Statements) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 03, 2015
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Condensed Financial Statements, Captions [Line Items]          
Revenues   $ 641,950 $ 278,227 $ 1,212,395 $ 537,788
Operating expenses:          
Salaries and benefits   320,396 84,053 622,575 166,202
Supply cost   45,790 40,873 88,374 78,678
Other operating expenses   105,002 55,812 195,572 109,981
Transaction costs   1,982 3,579 3,453 3,579
Depreciation and amortization   23,612 8,436 46,430 16,695
Total operating expenses   496,782 192,753 956,404 375,135
Gain (loss) on deconsolidation   (3,035) 1,366 (3,258) 3,411
Equity in earnings of unconsolidated affiliates   3,989 539 6,640 1,303
Operating income   146,122 87,379 259,373 167,367
Interest expense, net   30,182 6,892 60,429 13,852
Earnings from continuing operations before income taxes   115,940 80,487 198,944 153,515
Income tax expense   25,193 12,798 39,442 25,780
Net earnings from continuing operations   90,747 67,689 159,502 127,735
Net earnings from discontinued operations   0 483 0 551
Net earnings   90,747 68,172 159,502 128,286
Less net earnings attributable to noncontrolling interests   57,072 49,211 104,789 92,130
Net earnings attributable to AmSurg Corp. shareholders   33,675 18,961 54,713 36,156
Preferred stock dividends $ (2,300) (2,264) 0 (4,528) 0
Net earnings attributable to AmSurg Corp. common shareholders   31,411 18,961 50,185 36,156
Amounts attributable to AmSurg Corp. common shareholders:          
Earnings from continuing operations, net of income tax   31,411 18,771 50,185 36,163
Earnings (loss) from discontinued operations, net of income tax   0 190 0 (7)
Net earnings attributable to AmSurg Corp. common shareholders   31,411 18,961 50,185 36,156
Consolidation, Eliminations [Member]          
Condensed Financial Statements, Captions [Line Items]          
Revenues   (9,488) (4,777) (18,342) (9,386)
Operating expenses:          
Salaries and benefits   (124) (125) (252) (246)
Supply cost   (34) 0 (34) 0
Other operating expenses   (9,330) (4,652) (18,056) (9,140)
Transaction costs   0 0 0 0
Depreciation and amortization   0 0 0 0
Total operating expenses   (9,488) (4,777) (18,342) (9,386)
Gain (loss) on deconsolidation   0 (1,366) 188 (3,411)
Equity in earnings of unconsolidated affiliates   (137,455) (108,739) (249,774) (204,079)
Operating income   (137,455) (110,105) (249,586) (207,490)
Interest expense, net   0 0 0 0
Earnings from continuing operations before income taxes   (137,455) (110,105) (249,586) (207,490)
Income tax expense   0 0 0 0
Net earnings from continuing operations     (110,105)   (207,490)
Net earnings from discontinued operations     0   0
Net earnings   (137,455) (110,105) (249,586) (207,490)
Less net earnings attributable to noncontrolling interests   0 0 0 0
Net earnings attributable to AmSurg Corp. shareholders   (137,455) (110,105) (249,586) (207,490)
Preferred stock dividends   0   0  
Net earnings attributable to AmSurg Corp. common shareholders   (137,455)   (249,586)  
Amounts attributable to AmSurg Corp. common shareholders:          
Earnings from continuing operations, net of income tax     (110,105)   (207,490)
Earnings (loss) from discontinued operations, net of income tax     0   0
Net earnings attributable to AmSurg Corp. common shareholders   (137,455)   (249,586)  
Parent Company [Member]          
Condensed Financial Statements, Captions [Line Items]          
Revenues   7,079 6,364 14,170 12,491
Operating expenses:          
Salaries and benefits   15,511 15,282 33,154 29,767
Supply cost   0 0 0 0
Other operating expenses   5,783 4,849 12,417 9,015
Transaction costs   324 3,579 592 3,579
Depreciation and amortization   1,056 815 1,890 1,640
Total operating expenses   22,674 24,525 48,053 44,001
Gain (loss) on deconsolidation   0 1,366 (188) 3,411
Equity in earnings of unconsolidated affiliates   76,931 54,639 137,318 102,691
Operating income   61,336 37,844 103,247 74,592
Interest expense, net   11,978 6,341 23,864 12,793
Earnings from continuing operations before income taxes   49,358 31,503 79,383 61,799
Income tax expense   15,683 12,549 24,670 25,253
Net earnings from continuing operations     18,954   36,546
Net earnings from discontinued operations     7   (390)
Net earnings   33,675 18,961 54,713 36,156
Less net earnings attributable to noncontrolling interests   0 0 0 0
Net earnings attributable to AmSurg Corp. shareholders   33,675 18,961 54,713 36,156
Preferred stock dividends   (2,264)   (4,528)  
Net earnings attributable to AmSurg Corp. common shareholders   31,411   50,185  
Amounts attributable to AmSurg Corp. common shareholders:          
Earnings from continuing operations, net of income tax     18,954   36,546
Earnings (loss) from discontinued operations, net of income tax     7   (390)
Net earnings attributable to AmSurg Corp. common shareholders   31,411   50,185  
Guarantor Subsidiaries [Member]          
Condensed Financial Statements, Captions [Line Items]          
Revenues   329,579 0 615,158 0
Operating expenses:          
Salaries and benefits   228,618 0 440,219 0
Supply cost   489 0 885 0
Other operating expenses   42,099 0 71,710 0
Transaction costs   1,658 0 2,861 0
Depreciation and amortization   14,617 0 28,924 0
Total operating expenses   287,481 0 544,599 0
Gain (loss) on deconsolidation   (3,035) 1,366 (3,223) 3,411
Equity in earnings of unconsolidated affiliates   64,513 54,639 119,096 102,691
Operating income   103,576 56,005 186,432 106,102
Interest expense, net   17,624 0 35,378 0
Earnings from continuing operations before income taxes   85,952 56,005 151,054 106,102
Income tax expense   9,021 0 13,924 0
Net earnings from continuing operations     56,005   106,102
Net earnings from discontinued operations     0   0
Net earnings   76,931 56,005 137,130 106,102
Less net earnings attributable to noncontrolling interests   0 0 0 0
Net earnings attributable to AmSurg Corp. shareholders   76,931 56,005 137,130 106,102
Preferred stock dividends   0   0  
Net earnings attributable to AmSurg Corp. common shareholders   76,931   137,130  
Amounts attributable to AmSurg Corp. common shareholders:          
Earnings from continuing operations, net of income tax     56,005   106,102
Earnings (loss) from discontinued operations, net of income tax     0   0
Net earnings attributable to AmSurg Corp. common shareholders   76,931   137,130  
Non-Guarantor Subsidiaries [Member]          
Condensed Financial Statements, Captions [Line Items]          
Revenues   314,780 276,640 601,409 534,683
Operating expenses:          
Salaries and benefits   76,391 68,896 149,454 136,681
Supply cost   45,335 40,873 87,523 78,678
Other operating expenses   66,450 55,615 129,501 110,106
Transaction costs   0 0 0 0
Depreciation and amortization   7,939 7,621 15,616 15,055
Total operating expenses   196,115 173,005 382,094 340,520
Gain (loss) on deconsolidation   0 0 (35) 0
Equity in earnings of unconsolidated affiliates   0 0 0 0
Operating income   118,665 103,635 219,280 194,163
Interest expense, net   580 551 1,187 1,059
Earnings from continuing operations before income taxes   118,085 103,084 218,093 193,104
Income tax expense   489 249 848 527
Net earnings from continuing operations     102,835   192,577
Net earnings from discontinued operations     476   941
Net earnings   117,596 103,311 217,245 193,518
Less net earnings attributable to noncontrolling interests   57,072 49,211 104,789 92,130
Net earnings attributable to AmSurg Corp. shareholders   60,524 54,100 112,456 101,388
Preferred stock dividends   0   0  
Net earnings attributable to AmSurg Corp. common shareholders   60,524   112,456  
Amounts attributable to AmSurg Corp. common shareholders:          
Earnings from continuing operations, net of income tax     53,917   101,005
Earnings (loss) from discontinued operations, net of income tax     $ 183   $ 383
Net earnings attributable to AmSurg Corp. common shareholders   $ 60,524   $ 112,456